Medicalization of global health 2: the medicalization of global mental health

References

• Tomlinson M. Global mental health: a sustainable post Millennium Development Goal?. Int Health. 2013; 5: 1–3.
   Google Scholar
• Patel V, Thornicroft G. Packages of care for mental, neurological, and substance use disorders in low- and middle-income countries: PLoS Medicine Series. PLoS Med. 2009; 6: e1000160. [PubMed Abstract] [PubMed CentralFull Text].
   Google Scholar
• Patel V, Boyce N, Collins PY, Saxena A, Horton R. A renewed agenda for global mental health. Lancet. 2011; 378: 1441–42.
   Google Scholar
• Horton R. Launching a new movement for mental health. Lancet. 2007; 370: 806. [PubMed Abstract].
   Google Scholar
• The PLoS Medicine Editors. The paradox of mental health: over-treatment and under-recognition. PLoS Med. 2013; 10: e1001456.
   PubMed Web of Science ®Google Scholar
• Bass JK, Bornemann TH, Burkey M, Chehil S, Chen L, Copeland JRM. A United Nations general assembly special session for mental, neurological, and substance use disorders: the time has come. PLoS Med. 2012; 9(1): e1001159. [PubMed Abstract] [PubMed CentralFull Text].
   Google Scholar
• Movement for Global Mental Health. Available from: http://globalmentalhealth.org/ [cited 3 January 2014]..
   Google Scholar
• Clark J. Medicalization of global health 1: has the global health agenda become too medicalized?. Glob Health Action. 2014; 7: 23998.
   PubMed Web of Science ®Google Scholar
• Parens E. On good and bad forms of medicalization. Bioethics. 2013; 27: 28–35.
   Google Scholar
• Clark J. Medicalization of global health 3: the medicalization of the non-communicable diseases (NCD) agenda. Glob Health Action. 2014; 7: 24002.
   PubMed Web of Science ®Google Scholar
• Clark J. Medicalization of global health 4: the universal health coverage (UHC) campaign and the medicalization of global health. Glob Health Action. 2014; 7: 24004.
   PubMed Web of Science ®Google Scholar
• Baker MG, Kale R, Menken M. The wall between neurology and psychiatry. BMJ. 2002; 324: 1468.
   Google Scholar
• Beeme D, D'souza N. global mental health and its discontents. Available from: http://somatosphere.net/2012/07/global-mental-health-and-its-discontents.html [cited 3 January 2014].
   Google Scholar
• Collins PY, Patel V, Joestl SS, March D, Insel TR, Daar AS. Grand challenges in global mental health. Nature. 2011; 475: 27–30. [PubMed Abstract] [PubMed CentralFull Text].
   Google Scholar
• Benatar S. Global health: Where to now?. Global Health Governance 2008/2009. 11(2): Available from: http://www.ghgj.org/benatar2.2wherenow.htm [cited 3 January 2014]..
   Google Scholar
• White R. The globalisation of mental illness. Psychologist. 2013; 26: 182–5.
   Web of Science ®Google Scholar
• On the Medicalization of our Culture. April 23, 2009. Harvard Magazine. Available from: http://harvardmagazine.com/2009/04/medicalization-of-our-culture [cited 3 January 2014]..
   Google Scholar
• Campbell C, Burgess R. The role of communities in advancing the goals of the movement for global mental health. Transcult Psychiatr. 2012; 49: 379.
   PubMed Web of Science ®Google Scholar
• Summerfield D. “Global mental health” is an oxymoron and medical imperialism. BMJ. 2013; 346: 3509.
   PubMed Web of Science ®Google Scholar
• Summerfield D. Afterword: against ‘global mental health’. Transcult Psychiatr. 2012; 49: 1–12.
   Web of Science ®Google Scholar
• Summerfield D. How scientifically valid is the knowledge base of global mental health?. BMJ. 2008; 336: 992–4.
   Google Scholar
• Read UM, Adiibokah E, Nyame S. Local suffering and the global discourse of mental health and human rights: an ethnographic study of responses to mental illness in rural Ghana. Global Health. 2009; 5: 13. [PubMed Abstract] [PubMed CentralFull Text].
   Google Scholar
• Watters E January 10, 2010. The Americanization of Mental Illness. The New York Times. Available from: http://www.nytimes.com/2010/01/10/magazine/10psyche-t.html [cited 3 January 2014]..
   Google Scholar
• Jenkins R, Baingana F, Ahmad R, McDaid D, Atun R. Social, economic, human rights and political challenges to global mental health. Ment Health Fam Med. 2011; 8: 87–96. [PubMed Abstract] [PubMed CentralFull Text].
   Google Scholar
• Ngui EM, Khasakhala L, Ndetei D, Roberts LW. Mental disorders, health inequalities, and ethics: a global perspective. Int Rev Psychiatr. 2010; 22: 235–44.
   PubMed Web of Science ®Google Scholar
• Fernando G. The roads less traveled: mapping some pathways on the global mental health research roadmap. Transcult Psychiatr. 2012; 49: 396–417.
   PubMed Web of Science ®Google Scholar
• Kakuma R, Minas H, van Ginneken N, Dal Poz MR, Desiraju K, Morris JE, etal. Human resources for mental health care: current situation and strategies for action. Lancet. 2011; 378: 1654–63.
   Google Scholar
• Petersen I, Baillie K, Bhana A. for the Mental Health and Poverty Research Programme Consortium. Understanding the benefits and challenges of community engagement in the development of community mental health services for common mental disorders: lessons from a case study in a rural South African subdistrict site. Transcult Psychiatr. 2012; 49: 418–37.
   PubMed Web of Science ®Google Scholar
• Angell M. The Illusions of Psychiatry. 2011; July 14. The New York Review of Books. Available from: http://www.nybooks.com/articles/archives/2011/jul/14/illusions-of-psychiatry/?pagination=false [cited 3 January 2014]..
   Google Scholar
• Moynihan R, Doust J, Henry D. Preventing overdiagnosis: how to stop harming the healthy. BMJ. 2012; 344: e3502. [PubMed Abstract].
   Google Scholar
• Healy D. Did regulators fail over selective serotonin reuptake inhibitors?. BMJ. 2006; 333: 92.
   Google Scholar
• Kirsch I, Deacon BJ, Huedo-Medina TB, Scoboria A, Moore TJ, Johnson BT. Initial severity and antidepressant benefits: a meta-analysis of data submitted to the Food and Drug Administration. PLoS Med. 2008; 5: e45.
   Google Scholar
• Drugs for Treating Mental Disorders: Technologies and Global Markets. 2011. Available from: http://www.bccresearch.com/market-research/pharmaceuticals/mental-disorders-drugs-phm074a.html [cited 3 January 2014]..
   Google Scholar
• No author. Research-based pharmaceutical industry contributes to discussions on key global health issues at World Health Assembly. [press release]. Available from: http://www.ifpma.org/news/news-releases/news-details/article/research-based-pharmaceutical-industry-contributes.html [cited 3 January 2014]..
   Google Scholar
• Read U. “I want the one that will heal me completely so it won't come back again”: the limits of antipsychotic medication in rural Ghana. Transcult Psychiatr. 2012; 49: 438–60.
   PubMed Web of Science ®Google Scholar
• Han C, Biehl J, Petryna A. Labor instability and community mental health – the work of pharmaceuticals in Santiago, Chile. When people come first: critical studies in global health. 2013; Princeton: Princeton University Press. 276–301.
   Google Scholar
• Patel V, Weiss HA, Chowdhary N, Nalik S, Pednekar S, Chatterjee S, etal. Effectiveness of an intervention led by lay health counsellors for depressive and anxiety disorders in primary care in Goa, India (MANAS): a cluster randomised controlled trial. Lancet. 2010; 376: 2086–95.
   Google Scholar
• MGMH. Position statement on mental health in the post-2015 development agenda. No date. Available from: http://www.globalmentalhealth.org/mgmh-position-statement [cited 3 January 2014]..
   Google Scholar
• Lund C, Tomlinson M, De Silva M, Fekadu A, Shidhaye R, Jordans M. PRIME: a programme to reduce the treatment gap for mental disorders in five low- and middle-income countries. PLoS Med. 2012; 9: e1001359. [PubMed Abstract] [PubMed CentralFull Text].
   Google Scholar
• Loewenson R, Flores W, Shukla A, Kagis M, Baba A, Ryklief A, etal. Raising the profile of participatory action research at the 2010 Global Symposium on Health Systems Research. MEDICC Rev. 2011; 12: 35–8.
   Web of Science ®Google Scholar